Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
Triclofem DMPA
Product Overview
Alternative Name:
Triclovera, OSKB -1
Development Status:
Limited Market Approval
Target:
Female
Mode:
Hormonal
Delivery Type:
Injectable
Duration Type:
Long-acting
Description:
Three month contraceptive injection containing 150mg Depot Medroxyprogesterone Acetate (DMPA). It is manufactured by PT. Tunggal in Indonesia.
Updated date:
October 08, 2015
Vertical Tabs
Product Details
Active Pharmaceutical Ingredient (API):
medroxyprogesterone acetate
Potential Multi-Purpose Technology (MPT):
No
Duration:
3 months
Dose:
150 mg
Partner:
PT. Tunggal Idaman Abdi
Status
Project Phase:
Post-development
Project Stage:
Marketed
Status Details:
Manufactured by PT Tunggal in Indonesia and supplied to a limited number of countries. Currently undergoing review for WHO Prequalification.
Programmatic Considerations
Additional Information
Additional Information:
Company website:
www.tunggal-pharma.com
Download Product Report
